AGM/EGMJun 12, 2026, 04:12 PM
Century Therapeutics stockholders approve 450M authorized shares
AI Summary
Century Therapeutics, Inc. announced that its stockholders approved an amendment to increase the number of authorized shares of common stock from 300,000,000 to 450,000,000 at its Annual Meeting held on June 11, 2026. This amendment became effective on June 12, 2026. Additionally, Alessandro Riva, M.D. and Han Lee, Ph.D., M.B.A. were elected as Class II directors, and Ernst & Young LLP was ratified as the independent auditor for the 2026 fiscal year.
Key Highlights
- Stockholders approved increasing authorized common stock from 300,000,000 to 450,000,000 shares.
- The amendment to the Certificate of Incorporation became effective on June 12, 2026.
- Alessandro Riva, M.D. and Han Lee, Ph.D., M.B.A. were elected as Class II directors.
- Ernst & Young LLP was ratified as the independent auditor for the 2026 fiscal year.
- The authorized shares increase was approved with 117,444,445 votes For.
- Alessandro Riva received 96,165,182 votes For; Han Lee received 113,675,805 votes For.
- Auditor ratification received 135,560,408 votes For.
Price Impact
More from IPSC